Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

Direct‐acting antiviral therapies (DAAs) may improve kidney function and proteinuria in certain patients with hepatitis C infection (HCV) and chronic kidney disease (CKD). To improve our understanding of HCV‐mediated kidney dysfunction, we aimed to evaluate the baseline predictors of improvement in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Hepatol Commun
Huvudupphovsmän: Sise, Meghan E., Strohbehn, Ian, Chute, Donald, Corey, Kathleen E., Fusco, Dahlene N., Sabbisetti, Venkata S, Waikar, Sushrut S., Chung, Raymond T.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7395066/
https://ncbi.nlm.nih.gov/pubmed/32766479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1528
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk